Analog Devices (NASDAQ: ADI) CEO reports 10,000-share sale and option exercise

Q: What insider stock transactions did Analog Devices (ADI) report for Vincent Roche?

The report shows that Vincent Roche exercised 10,000 non-qualified stock options for Analog Devices common stock and sold 10,000 common shares on December 12, 2025 .

Q: At what prices did Vincent Roche exercise and sell Analog Devices (ADI) shares?

Roche exercised options at an exercise price of $94.41 per share and sold the resulting Analog Devices common shares at $282.42 per share .

Q: How many Analog Devices (ADI) shares does Vincent Roche own after the December 12, 2025 transactions?

After the transactions, Roche directly owned 155,688.462 Analog Devices common shares, with 23,515 additional shares held indirectly through the Vincent Roche 2024 Grantor Retained Annuity Trust , plus 64,637 non-qualified stock options.

Q: Was the Analog Devices (ADI) CEO’s stock sale made under a Rule 10b5-1 trading plan?

Yes. The 10,000-share sale was made pursuant to a Rule 10b5-1 trading plan adopted by Vincent Roche on May 23, 2025 .

Q: What positions does Vincent Roche hold at Analog Devices (ADI)?

Vincent Roche is reported as a Director and an Officer , serving as Chair & CEO of Analog Devices.

Q: What are the key terms of Vincent Roche’s exercised stock option in Analog Devices (ADI)?

The exercised instrument was a non-qualified stock option to buy 10,000 Analog Devices common shares at $94.41 per share, originally granted on March 15, 2021 with an expiration date of March 11, 2030 , and it is stated to be fully vested .

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Vincent Roche, Chair, CEO and Director of Analog Devices, exercised 10,000 non-qualified stock options for common stock at an exercise price of $94.41 per share on December 12, 2025. The options were fully vested and related to 10,000 shares of Analog Devices common stock.

On the same date, Roche sold 10,000 shares of Analog Devices common stock at $282.42 per share under a pre-arranged Rule 10b5-1 trading plan adopted on May 23, 2025. After these transactions, he directly held 155,688.462 common shares, an additional 23,515 shares were held indirectly through the Vincent Roche 2024 Grantor Retained Annuity Trust, and 64,637 non-qualified stock options remained beneficially owned.

Insider Trade Summary

Net Seller: 10,000 shares ($2,824,200)

Net Sell 4 txns

Insider ROCHE VINCENT

Role Chair & CEO

Sold 10,000 shs ($2.82M)

Type	Security	Shares	Price	Value
Exercise	Non-Qualified Stock Option (right to buy)	10,000	$94.41	$944K
Exercise	Comm Stock - $.16-2/3 value	10,000	$94.41	$944K
Sale	Comm Stock - $.16-2/3 value	10,000	$282.42	$2.82M
holding	Comm Stock-$.16-2/3 value	--	--	--

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 64,637 shares (Direct); Comm Stock - $.16-2/3 value — 165,688.462 shares (Direct); Comm Stock-$.16-2/3 value — 23,515 shares (Indirect, Vincent Roche 2024 Grantor Retained Annuity Trust)

Footnotes (1)

These shares were sold pursuant to a 10b5-1 plan adopted by the Reporting Person on May 23, 2025. Shares held by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024. This option is fully vested.

Form 4 Insider Transactions: What Each Field Means →

12/15/2025 - 04:08 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROCHE VINCENT

(Last)

(First)

(Middle)

ONE ANALOG WAY

(Street)

WILMINGTON

01887

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
ANALOG DEVICES INC [ ADI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chair & CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Comm Stock - $.16-2/3 value	12/12/2025		M		10,000	A	$94.41	165,688.462	D
Comm Stock - $.16-2/3 value	12/12/2025		S		10,000⁽¹⁾	D	$282.42	155,688.462	D
Comm Stock-$.16-2/3 value								23,515	I⁽²⁾	Vincent Roche 2024 Grantor Retained Annuity Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Non-Qualified Stock Option (right to buy)	$94.41	12/12/2025		M			10,000	03/15/2021⁽³⁾	03/11/2030	Comm Stock - $.16-2/3 value	10,000	$94.41	64,637	D

Explanation of Responses:

1. These shares were sold pursuant to a 10b5-1 plan adopted by the Reporting Person on May 23, 2025.

2. Shares held by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024.

3. This option is fully vested.

Remarks:

	/s/ Shelly Shaw, General Counsel, by Power of Attorney	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider stock transactions did Analog Devices (ADI) report for Vincent Roche?

The report shows that Vincent Roche exercised 10,000 non-qualified stock options for Analog Devices common stock and sold 10,000 common shares on December 12, 2025.

At what prices did Vincent Roche exercise and sell Analog Devices (ADI) shares?

Roche exercised options at an exercise price of $94.41 per share and sold the resulting Analog Devices common shares at $282.42 per share.

How many Analog Devices (ADI) shares does Vincent Roche own after the December 12, 2025 transactions?

After the transactions, Roche directly owned 155,688.462 Analog Devices common shares, with 23,515 additional shares held indirectly through the Vincent Roche 2024 Grantor Retained Annuity Trust, plus 64,637 non-qualified stock options.

Was the Analog Devices (ADI) CEO’s stock sale made under a Rule 10b5-1 trading plan?

Yes. The 10,000-share sale was made pursuant to a Rule 10b5-1 trading plan adopted by Vincent Roche on May 23, 2025.

What positions does Vincent Roche hold at Analog Devices (ADI)?

Vincent Roche is reported as a Director and an Officer, serving as Chair & CEO of Analog Devices.

What are the key terms of Vincent Roche’s exercised stock option in Analog Devices (ADI)?

The exercised instrument was a non-qualified stock option to buy 10,000 Analog Devices common shares at $94.41 per share, originally granted on March 15, 2021 with an expiration date of March 11, 2030, and it is stated to be fully vested.